Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatitis C Reinfection After Successful Directly Acting Antiviral Treatment: A Belgian Interventional Multicenter Study

NCT04251572 is registered in ClinicalTrials.gov with Hasselt University as lead sponsor.

NCT NCT04251572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04251572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatitis C Reinfection After Successful Directly Acting Antiviral Treatment: A Belgian Interventional Multicenter Study
Lead sponsor
Hasselt University
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2019
Completion date
February 28, 2022
Enrollment
100 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

drug use, hepatitis c virus infection, response to therapy of